Background. The neutrophil-lymphocyte ratio (NLR) refl ects infl ammatory status. An elevated NLR has been reported to be a prognostic indicator in some malignant tumors. The aim of this study was to evaluate the clinical signifi cance of the preoperative NLR in patients with primary gastric cancer. Results. The 5-year survival of patients with a high NLR was signifi cantly worse than that of patients with a low NLR (57% vs 82%, P < 0.001). Univariate and multivariate analyses of clinicopathological factors affecting survival revealed that high NLR, depth of tumor, positive lymph nodes, distant metastasis, peritoneal metastasis, poorly differentiated type, and high platelet count were signifi cant risk factors for reduced survival. On multivariate analysis, after adjusting for tumor stage, a high NLR was an independent risk factor for reduced survival (P = 0.003; adjusted hazard ratio, 1.845; 95% confidence interval, 1.236-2.747). Conclusion. A high preoperative NLR may be a convenient biomarker to identify patients with a poor prognosis after resection for primary gastric cancer.
Introduction
Although preoperative tumor staging is useful to select the appropriate therapeutic strategy for patients with gastric cancer, clinical tumor staging alone cannot predict patients' prognosis. A few serum markers were found to be associated with poor prognosis in patients with gastric cancer and are therefore useful for monitoring and predicting early recurrence and poor prognosis [1, 2] . The host infl ammatory response to cancer cells is also associated with tumor progression [3, 4] . In advanced tumors, a high preoperative C-reactive protein level and/or high platelet count were frequently observed and were associated with poor patient prognosis [5, 6] . The preoperative neutrophil-lymphocyte ratio (NLR) also refl ects patients' infl ammation status, clinical stage, and patients' survival in colon cancer, lung cancer, and liver cancer [7] [8] [9] [10] [11] [12] . Increased numbers of neutrophils and/or decreased numbers of lymphocytes may suppress lymphokine-activated killer cells, thereby increasing the propensity to metastasis [13] . However, only limited information on the clinical signifi cance and prognostic signifi cance of NLR in patients with gastric cancer has been reported [14] [15] [16] [17] . In this study, we measured the preoperative NLR in 1028 patients with primary gastric cancer to determine its clinicopathological and prognostic signifi cance.
Patients and methods

Patients
Between 2001 and 2007, a total of 1028 patients with primary gastric adenocarcinoma who underwent gastrectomy at the Department of Gastroenterological Surgery of Chiba Cancer Center were investigated. The patient population consisted of 709 men (69%) and 319 women (31%), with a median age of 65 years (range, 26 to 89 years). All patients underwent either a total or subtotal gastrectomy with standard lymphadenectomy. The resected specimens were pathologically classifi ed according to the 13 th edition (2 nd English edition) of the Japanese classifi cation of gastric carcinoma [18] . The distribution of cancer stages was as follows: stage I, 584; stage II, 132; stage III, 153; and stage IV, 159. All patients were followed up regularly until December 2008 or until death. The follow-up period ranged from 12 months to 84 months (median, 23 months).
Blood sample analyses
Peripheral blood was obtained at the time of diagnosis before surgery. The numbers of white blood cells and platelets were determined with a hemocytometer. The percentages of particular types of cells were determined by using a Coulter LH 750 Hematology Analyzer (Coulter, Brea, CA, USA). Absolute counts of particular cells were calculated by multiplying the percentage of particular cells by the number of white blood cells. NLR values were expressed as means ± SD. An NLR value of 4.0 was used as a cutoff value,. classify high NLR (≥4) and low NLR groups.
Statistical analyses
NLR values were compared using the Mann-Whitney U-test. Fisher's exact probability test was used to determine the signifi cance of differences between two groups. Survival probabilities were calculated using the product limit method of Kaplan and Meier, considering overall deaths. Survival differences between groups were determined using the log-rank test. The infl uence of each signifi cant predictor identifi ed by univariate analysis was assessed by multivariate analysis using Cox's proportional hazards model. The infl uence of each clinicopathological variable on the risk of high NLR was assessed by logistic regression analysis. All statistical analyses were carried out using Stat View 5.0 for Windows (SAS Institute, Cary, NC, USA). All P values less than 0.05 were considered statistically signifi cant.
Results
Preoperative NLR and clinicopathological variables
The mean preoperative NLR in the 1028 patients was 2.62 ± 1.68, with a median of 2.23 (range, 0.38 to 21.86). The distribution of all patients according to NLR was as follows; NLR < 1.0, n = 32; 1.0 ≤ NLR < 2.0, n = 381; 2.0 ≤ NLR < 3.0, n = 321; 3.0 ≤ NLR < 4.0; n = 167; 4.0 ≤ NLR < 5.0, n = 75; and 5.0 ≤ NLR, n = 52. We then analyzed the data to determine statistically signifi cant differences between each combination of groups according to NLR. Log-rank P values were calculated as P = 0.102 (NLR < 1.0 vs 1.0 ≤ NLR < 2.0), P = 0.272 (1.0 < NLR < 2.0 vs 2.0 ≤ NLR < 3.0), P = 0.050 (2.0 ≤ NLR < 3.0 vs 3.0 ≤ NLR < 4.0), P = 0.027 (3.0 ≤ NLR < 4.0 vs 4.0 ≤ NLR < 5.0), and P = 0.602 (4.0 ≤ NLR < 5.0 vs 5.0 ≤ NLR). Based on these results, we decided to use 4.0 as a cutoff value to predict patients' prognoses.
Based on the cutoff value of 4.0, 127 of the 1028 (12.4%) patients were classifi ed in the high NLR group. Signifi cant differences were observed in the values of NLR according to age, tumor depth, nodal status, distant metastasis, peritoneal metastasis, and platelet count ( Table 1) . Signifi cant differences were observed in the percentages of patients with high NLR according to tumor depth, nodal status, peritoneal metastasis, and platelet count (Table 1) . Patients with peritoneal metastasis (32.7%) most frequently had high NLR values.
NLR gradually increased with increasing tumor stage, from 2.37 ± 1.41 in stage I, 2.38 ± 1.17 in stage II, and 3.04 ± 2.03 in stage III to 3.34 ± 2.25 in stage IV (Fig. 1A) . Although NLR values signifi cantly increased according to tumor depth (Fig. 1B) , NLR values did not signifi cantly increase according to the extent of nodal metastases, N1, N2, and N3 (Fig. 1C) . The percentage of patients with high NLR increased slightly in each stage, as follows; 8.4% in stage I, 9.8% in stage II, 19.6% in stage III, and 22.0% in stage IV (Fig. 1D) .
To evaluate the effect of clinicopathological variables on NLR increases, logistic regression analysis was performed. Being elderly (age 65 or more) and/or being thrombocytotic were identifi ed as independent risk factors for high NLR (Table 2) .
Prognostic signifi cance of preoperative NLR
A total of 147 patients died by the end of 2008; 128 of these 147 patients (87%) died due to gastric cancer. To investigate whether a high NLR value refl ected a poor prognosis for patients, a Kaplan-Meier analysis and a log-rank test were carried out. The overall survival rates gradually declined with increasing NLR. Based on the survival curves obtained after dividing the patients into six groups ( Fig. 2A) , 4.0 seemed to be an appropriate cutoff value to distinguish a high-risk group with a poor prognosis (Fig. 2B) .
In regard to the clinicopathological factors evaluated, a signifi cantly poor survival was observed in patients classifi ed as elderly (age 65 or more), patients with T3 or T4, N1, M1, P1; poorly differentiated type; high platelet count; and high NLR (Table 3) . After adjusting for TNM stages, high NLR groups showed signifi cantly poorer survival than did low NLR groups in stages I, II, and IV, and a borderline difference was observed in stage III (Fig. 3) . All signifi cant prognostic factors and platelet counts tested by univariate analysis were evaluated by Cox's proportional hazards model. Tumor progression, high platelet count, poorly differentiated type, and high NLR were independent risk factors for reduced patient survival (Table 3) .
Discussion
In the present study, a high preoperative NLR value in patients with gastric cancer was found to be associated with tumor progression and poor prognosis. The gradual increase in NLR may be caused by peritumoral infl ammation produced by a large number of cancer cells in patients with advanced carcinoma. Several studies have shown that high preoperative NLR values in patients with different types of carcinoma were associated with a poor prognosis [8] [9] [10] [11] [12] . Similarly, in our study, the prognosis of patients with a high NLR was signifi cantly worse than that of patients with a low NLR. Because NLR was signifi cantly associated with tumor progression, the difference in survival may be partly explained by differences in tumor volumes between the low and high NLR groups. After controlling for these pathological parameters by multivariate analysis, the NLR was still shown to be an independent prognostic factor separate from TNM factors.
The cutoff value used in the present study was different from those in previous reports (2.0, 2.5, or 5.0) [12, 14, 15] . We, fi rst of all, analyzed overall survival curves according to each NLR value, from a minimum level (<1.0) to the highest level (5.0 ≤). Based on univariate analysis of these survival curves, 4.0 was the best cutoff Survival Months Survival Months Fig. 2A,B . Kaplan-Meier survival curves, stratifi ed by pretreatment neutrophil-lymphocyte ratio (NLR), in 1028 patients with gastric carcinoma. A Divided into six groups, and B divided into two groups (P < 0.001). P values were determined using the log-rank test . The inconsistency of survival between the NLR < 1 group and the 1 ≤ NLR < 3 group may have been due to the small number of patients in the former group. Based on univariate analysis, an NLR of 3.0 was also potentially useful as a cutoff value to predict patients' survival. When an NLR of 3.0 was used as a cutoff value in multivariate analysis, the multivariate P value was 0.0309 and the adjusted hazard ratio was 1.466. On the other hand, when an NLR of 4.0 was used as a cutoff value in multivariate analysis, the multivariate P value was 0.0027 and the adjusted hazard ratio was 1.845. Although both cutoff values were statistically signifi cant to predict patients' prognosis, an NLR of 4.0 seemed to be a more useful cutoff value than an NLR of 3.0.
A high NLR refl ects an increased neutrophil count and/or a decreased lymphocyte count. Teramukai et al. [19] reported that an increased neutrophil count in itself was an independent risk factor for reduced survival in non-small cell lung cancer. In our present study of a group with gastric cancer, however, although the neutrophil count in itself was not an independent risk factor (data not shown), the NLR was selected as an independent risk factor for reduced survival.
Recent developments in cancer immunotherapy, and the relationship shown between lymphocyte-neutrophil numbers and prognosis in the present study could be related, and could be exploited to elucidate the response and effectiveness of cancer immunotherapy [20] [21] [22] .
The major limitation of the present study was that the blood fi ndings were not compared to fi ndings such as peritumoral infl ammation in the primary tumor tissue. Therefore, the notion that the increase in the NLR with stage is related to an increase in peri-tumoral infl ammation is highly speculative. A comparison between the NLR and data for the numbers and specifi c cell types involved in peritumoral infl ammation could have provided a potential functional explanation for our fi ndings, which at present, are purely descriptive in nature. Such a comparison could have given some new insight into the relationship between the NLR and prognosis in gastric cancer patients.
The platelet count is another convenient parameter within the blood cell count that can help to predict patients' survival. An increased platelet count, thrombocytosis, was reported as an independent risk factor for reduced survival in advanced gastric cancer and esophageal cancer [6, 23] . Therefore, we co-analyzed high platelet count with tumor stages and high NLR in our multivariate analysis. A high NLR was revealed to be associated with a high platelet count, and moreover, was selected as an independent risk factor for reduced survival.
Because a peripheral blood cell count is a quick and easy assay to perform, measurement of the NLR may be useful as a clinical biological marker, not only to estimate tumor load but also to predict prognosis in patients with gastric cancer.
